Ebola Outbreak Not a Global Health Emergency, Declares WHO

The agency also shares preliminary results of an Ebola vaccine trial showing that it is 97.5 percent effective at protecting from infection.

Written byChia-Yi Hou
| 2 min read
world health organization who ebola decision health emergency vaccine efficacy

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM
MSEIDELCH

In a decision announced on April 12, the World Health Organization does not declare the Ebola outbreak in Democratic Republic of Congo a global health emergency because the disease is currently limited to two provinces, reports Science. On the same day, WHO reported the efficacy of an Ebola vaccine that is going through a preliminary trial to be 97.5 percent at preventing infection, reports STAT.

The current outbreak began in August 2018, and 1,200 cases have been reported since then, reports STAT.

“It was an almost unanimous vote that this would not constitute a PHEIC (public health emergency of international concern) because we are moderately optimistic that this outbreak can be brought into control—not immediately, but still within a foreseeable time,” Robert Steffen of the University of Zurich who chaired the WHO panel said at a news conference, reports Reuters.

The previous Ebola outbreak in Sierra Leone, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of small blue creatures called Nergals. Some have hearts above their heads, which signify friendship. There is one Nergal who is sneezing and losing health, which is denoted by minus one signs floating around it.
June 2025, Issue 1

Nergal Networks: Where Friendship Meets Infection

A citizen science game explores how social choices and networks can influence how an illness moves through a population.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

agilent-logo

Agilent Announces the Enhanced 8850 Gas Chromatograph

parse-biosciences-logo

Pioneering Cancer Plasticity Atlas will help Predict Response to Cancer Therapies